Nomura Holdings’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-3,398
Closed -$393K 1559
2018
Q2
$393K Buy
+3,398
New +$373K ﹤0.01% 1059
2017
Q2
Sell
-53,501
Closed -$6.24M 1639
2017
Q1
$6.24M Buy
+53,501
New +$5.92M 0.02% 404
2016
Q2
Sell
-4,883
Closed -$698K 1692
2016
Q1
$698K Buy
4,883
+1,636
+50% +$232K ﹤0.01% 781
2015
Q4
$502K Sell
3,247
-2,159
-40% -$315K ﹤0.01% 1080
2015
Q3
$755K Buy
5,406
+1,004
+23% +$140K ﹤0.01% 835
2015
Q2
$619K Buy
+4,402
New +$628K ﹤0.01% 1181
2014
Q3
Sell
-2,081
Closed -$286K 3108
2014
Q2
$286K Buy
2,081
+137
+7% +$15.2K ﹤0.01% 2168
2014
Q1
$216K Sell
1,944
-2,244
-54% -$244K ﹤0.01% 2285
2013
Q4
$414K Buy
4,188
+1,477
+54% +$128K ﹤0.01% 1369
2013
Q3
$203K Sell
2,711
-2,389
-47% -$155K ﹤0.01% 1903
2013
Q2
$284K Buy
+5,100
New +$301K ﹤0.01% 1636

Other funds holding TARO

Nomura Holdings's TARO Position: Q3 2018 in Review

Nomura Holdings sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2018, closing a stake of 3,398 shares — an estimated $393K sold.

Nomura Holdings first reported a position in TARO in Q2 2013 and held it in 11 quarters. The position peaked at $6.24M in Q1 2017. 114 funds tracked by Wall St. Rank hold TARO as of Q3 2018.

  • Nomura Holdings reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2018 after selling out during the quarter.
  • Nomura Holdings sold 3,398 Taro Pharmaceutical Industries Ltd. shares in Q3 2018, an estimated $393K.
  • Nomura Holdings first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and held it in 11 quarters.
  • Nomura Holdings's Taro Pharmaceutical Industries Ltd. position peaked at $6.24M in Q1 2017.
  • 114 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2018.

Based on Nomura Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.